SNCA and Parkinson disease: The recently proposed neuronal α-synuclein disease integrated staging system defines Parkinson’s disease biologically by the presence of pathological α-synuclein, dopaminergic neuron dysfunction, and pathogenic variants in the SNCA gene.13